文献速递临床试验与 GCP基础与转化研究

罗哌卡因头皮神经阻滞用于小儿开颅术后镇痛:前瞻性随机安慰剂对照双盲试验方案

Postoperative analgesia of scalp nerve block with ropivacaine in pediatric craniotomy patients: a protocol for a prospective, randomized, placebo-controlled, double-blinded trial.
PubMed 文献 · Trials · 2020-06-26

本研究为单中心前瞻性随机对照双盲试验方案,计划纳入180例1–12岁择期开颅患儿,按1:1:1随机分为术前罗哌卡因头皮神经阻滞组、术后罗哌卡因头皮神经阻滞组和不阻滞对照组,按年龄1–6岁与7–12岁分层。主要结局为术后24小时内舒芬太尼总用量,次要结局包括疼痛评分、各观察点舒芬太尼及补救药物用量、术后并发症和术后住院时间。

要点

  • 小儿开颅术后中重度疼痛发生率高,可致躁动、颅内高压、癫痫发作和术后血肿。
  • 罗哌卡因头皮神经阻滞用于小儿开颅术后镇痛的研究较少,术前与术后阻滞时机优劣待验证。
  • 主要结局为术后24小时舒芬太尼总用量,试验注册号ChiCTR1800017386。

核心结论

  • 该方案旨在探讨罗哌卡因头皮神经阻滞用于小儿开颅术后镇痛的效果与可行性,并比较术前与术后阻滞对术后镇痛的影响。

研究设计与样本

  • 单中心、前瞻性、随机、对照、双盲试验方案,计划纳入180例1–12岁择期开颅患儿。
  • 按1:1:1随机分为术前罗哌卡因阻滞组(B组)、术后罗哌卡因阻滞组(A组)和不阻滞对照组(N组),按年龄1–6岁与7–12岁分层。
  • 主要结局为术后24小时内舒芬太尼总用量。

关键数值与推荐

  • 次要结局包括疼痛评分评估、各观察点舒芬太尼总用量和补救药物用量、术后并发症发生情况以及术后住院时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Moderate-to-severe postoperative pain following craniotomy has a high incidence in pediatric patients. Such pain may cause agitation, intracranial hypertension, epileptic seizures, and postoperative hematoma, which affect morbidity and mortality. Although scalp nerve block (SNB) achieves satisfactory pain relief except for suboccipital mid-craniotomy in adults and ropivacaine is widely used as a long-acting peripheral nerve block agent in children, there are few studies of SNB with ropivacaine in pediatric patients undergoing craniotomy. In addition, the neurosurgery operation time is relatively long, but the duration of action of SNB is limited. It is generally believed that postoperative SNB is better than preoperative SNB for postoperative analgesia. However, considering the concept of preemptive analgesia, we believe that preoperative SNB may achieve a longer postoperative analgesia effect than we expected. METHODS: This trial is a single-institution, prospective, randomized, controlled, double-blind study. A total of 180 children aged between 1 and 12 years who are undergoing elective craniotomy will be randomly allocated in a 1:1:1 ratio to three groups: group B (preoperative ropivacaine block group), group A (postoperative ropivacaine block group), and group N (nonblocking control group). This randomization will be stratified by age in two strata (1-6 years and 7-12 years). The primary outcome is the total consumption of sufentanil within 24 h after surgery. The secondary outcomes include assessment of pain scores, total consumption of sufentanil and emergency-remedy medicine consumption at observation points, the occurrence of postoperative complications, and the length of hospitalization after surgery. DISCUSSION: This study is designed to explore the effect and feasibility of SNB with ropivacaine for postoperative analgesia in pediatric patients undergoing craniotomy. Further aims are to compare the effects of preoperative and postoperative SNB on postoperative analgesia in order to identify whether there is a preemptive analgesic effect and determine the better time to implement SNB in pediatric patients during craniotomy. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800017386. Registered on 27 July 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xiong W, Li L, Bao D, et al. Postoperative analgesia of scalp nerve block with ropivacaine in pediatric craniotomy patients: a protocol for a prospective, randomized, placebo-controlled, double-blinded trial. Trials. 2020. PMID: 32586348. doi:10.1186/s13063-020-04524-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。